Clinical trial
A Randomized Trial of Mifepristone Antagonization With High-Dose Progesterone to Prevent Medical Abortion
NCT03774745 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of Mifepristone Antagonization With High-Dose Progesterone to Prevent Medical Abortion
- Lead sponsor
- University of California, Davis
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- February 11, 2019
- Completion date
- August 15, 2019
- Enrollment
- 12 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
pregnancy, unwanted